Matricellular proteins tune myeloid-derived suppressor cell recruitment and function in breast cancer

Journal of Leukocyte Biology

Volumn 102, Issue 2, 2017, Pages 287-292

  Chiodoni, Claudia ^a   Sangaletti, Sabina ^a   Colombo, Mario P ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

Extracellular matrix; Osteopontin; SPARC; Tumor

Indexed keywords

CELL PROTEIN; MATRICELLULAR PROTEIN; OSTEONECTIN; OSTEOPONTIN; UNCLASSIFIED DRUG;

BREAST CANCER; BREAST CARCINOGENESIS; EPITHELIAL MESENCHYMAL TRANSITION; EXTRAMEDULLARY HEMATOPOIESIS; MYELOID-DERIVED SUPPRESSOR CELL; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; REVIEW; TUMOR MICROENVIRONMENT; BREAST TUMOR; CANCER STEM CELL; FEMALE; HUMAN; IMMUNOLOGY;

BREAST NEOPLASMS; FEMALE; HUMANS; MYELOID-DERIVED SUPPRESSOR CELLS; NEOPLASTIC STEM CELLS; TUMOR MICROENVIRONMENT;

EID: 85026784589     PISSN: 07415400     EISSN: 19383673     Source Type: Journal    
DOI: 10.1189/jlb.3MR1016-447R     Document Type: Review

References (34)

1. Pickup, M. W., Mouw, J. K., Weaver, V. M. (2014) The extracellular matrix modulates the hallmarks of cancer. EMBO Rep. 15, 1243–1253.
2. Chiodoni, C., Colombo, M. P., Sangaletti, S. (2010) Matricellular proteins: from homeostasis to inflammation, cancer, and metastasis. Cancer Metastasis Rev. 29, 295–307.
3. Sangaletti, S., Stoppacciaro, A., Guiducci, C., Torrisi, M. R., Colombo, M. P. (2003) Leukocyte, rather than tumor-produced SPARC, determines stroma and collagen type IV deposition in mammary carcinoma. J. Exp. Med. 198, 1475–1485.
4. Sangaletti, S., Tripodo, C., Cappetti, B., Casalini, P., Chiodoni, C., Piconese, S., Santangelo, A., Parenza, M., Arioli, I., Miotti, S., Colombo, M. P. (2011) SPARC oppositely regulates inflammation and fibrosis in bleomycin-induced lung damage. Am. J. Pathol. 179, 3000–3010.
5. Tripodo, C., Sangaletti, S., Guarnotta, C., Piccaluga, P. P., Cacciatore, M., Giuliano, M., Franco, G., Chiodoni, C., Sciandra, M., Miotti, S., Calvaruso, G., Carè, A., Florena, A. M., Scotlandi, K., Orazi, A., Pileri, S. A., Colombo, M. P. (2012) Stromal SPARC contributes to the detrimental fibrotic changes associated with myeloproliferation whereas its deficiency favors myeloid cell expansion. Blood 120, 3541–3554.
6. Wong, G. S., Rustgi, A. K. (2013) Matricellular proteins: priming the tumour microenvironment for cancer development and metastasis. Br. J. Cancer 108, 755–761.
7. Shinohara, M. L., Kim, H. J., Kim, J. H., Garcia, V. A., Cantor, H. (2008) Alternative translation of osteopontin generates intracellular and secreted isoforms that mediate distinct biological activities in dendritic cells. Proc. Natl. Acad. Sci. USA 105, 7235–7239.
8. Shinohara, M. L., Lu, L., Bu, J., Werneck, M. B., Kobayashi, K. S., Glimcher, L. H., Cantor, H. (2006) Osteopontin expression is essential for interferon-alpha production by plasmacytoid dendritic cells. Nat. Immunol. 7, 498–506.
9. Bronte, V., Brandau, S., Chen, S. H., Colombo, M. P., Frey, A. B., Greten, T. F., Mandruzzato, S., Murray, P. J., Ochoa, A., Ostrand-Rosenberg, S., Rodriguez, P. C., Sica, A., Umansky, V., Vonderheide, R. H., Gabrilovich, D. I. (2016) Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards. Nat. Commun. 7, 12150.
10. Nagaraj, S., Gabrilovich, D. I. (2008) Tumor escape mechanism governed by myeloid-derived suppressor cells. Cancer Res. 68, 2561–2563.
11. Marvel, D., Gabrilovich, D. I. (2015) Myeloid-derived suppressor cells in the tumor microenvironment: expect the unexpected. J. Clin. Invest. 125, 3356–3364.
12. Youn, J. I., Nagaraj, S., Collazo, M., Gabrilovich, D. I. (2008) Subsets of myeloid-derived suppressor cells in tumor-bearing mice. J. Immunol. 181, 5791–5802.
13. Peranzoni, E., Zilio, S., Marigo, I., Dolcetti, L., Zanovello, P., Mandruzzato, S., Bronte, V. (2010) Myeloid-derived suppressor cell heterogeneity and subset definition. Curr. Opin. Immunol. 22, 238–244.
14. Dolcetti, L., Peranzoni, E., Ugel, S., Marigo, I., Fernandez Gomez, A., Mesa, C., Geilich, M., Winkels, G., Traggiai, E., Casati, A., Grassi, F., Bronte, V. (2010) Hierarchy of immunosuppressive strength among myeloid-derived suppressor cell subsets is determined by GM-CSF. Eur. J. Immunol. 40, 22–35.
15. Movahedi, K., Guilliams, M., Van den Bossche, J., Van den Bergh, R., Gysemans, C., Beschin, A., De Baetselier, P., Van Ginderachter, J. A. (2008) Identification of discrete tumor-induced myeloid-derived suppressor cell subpopulations with distinct T cell-suppressive activity. Blood 111, 4233–4244.
16. Huang, B., Pan, P. Y., Li, Q., Sato, A. I., Levy, D. E., Bromberg, J., Divino, C. M., Chen, S. H. (2006) Gr-1+CD115+ immature myeloid suppressor cells mediate the development of tumor-induced T regulatory cells and T-cell anergy in tumor-bearing host. Cancer Res. 66, 1123–1131.
17. Mao, Y., Poschke, I., Wennerberg, E., Pico de Coaña, Y., Egyhazi Brage, S., Schultz, I., Hansson, J., Masucci, G., Lundqvist, A., Kiessling, R. (2013) Melanoma-educated CD14+ cells acquire a myeloid-derived suppressor cell phenotype through COX-2-dependent mechanisms. Cancer Res. 73, 3877–3887.
18. Serafini, P. B. (2014) Myeloid-derived suppressor cells in tumor-induced T cell suppression and tolerance. In Tumor-Induced Immune Suppression, Springer-Verlag, New York, 99–150.
19. Sangaletti, S., Tripodo, C., Sandri, S., Torselli, I., Vitali, C., Ratti, C., Botti, L., Burocchi, A., Porcasi, R., Tomirotti, A., Colombo, M. P., Chiodoni, C. (2014) Osteopontin shapes immunosuppression in the metastatic niche. Cancer Res. 74, 4706–4719.
20. Sangaletti, S., Tripodo, C., Santangelo, A., Castioni, N., Portararo, P., Gulino, A., Botti, L., Parenza, M., Cappetti, B., Orlandi, R., Tagliabue, E., Chiodoni, C., Colombo, M. P. (2016) Mesenchymal transition of high-grade breast carcinomas depends on extracellular matrix control of myeloid suppressor cell activity. Cell Reports 17, 233–248.
21. Furger, K. A., Menon, R. K., Tuck, A. B., Bramwell, V. H., Chambers, A. F. (2001) The functional and clinical roles of osteopontin in cancer and metastasis. Curr. Mol. Med. 1, 621–632.
22. Zhu, A., Yuan, P., Du, F., Hong, R., Ding, X., Shi, X., Fan, Y., Wang, J., Luo, Y., Ma, F., Zhang, P., Li, Q., Xu, B. (2016) SPARC overexpression in primary tumors correlates with disease recurrence and overall survival in patients with triplenegative breast cancer. Oncotarget 7, 76628–76634.
23. Kusmartsev, S., Gabrilovich, D. I. (2006) Effect of tumor-derived cytokines and growth factors on differentiation and immune suppressive features of myeloid cells in cancer. Cancer Metastasis Rev. 25, 323–331.
24. Kim, E. K., Jeon, I., Seo, H., Park, Y. J., Song, B., Lee, K. A., Jang, Y., Chung, Y., Kang, C. Y. (2014) Tumor-derived osteopontin suppresses antitumor immunity by promoting extramedullary myelopoiesis. Cancer Res. 74, 6705–6716.
25. Triulzi, T., Casalini, P., Sandri, M., Ratti, M., Carcangiu, M. L., Colombo, M. P., Balsari, A., Ménard, S., Orlandi, R., Tagliabue, E. (2013) Neoplastic and stromal cells contribute to an extracellular matrix gene expression profile defining a breast cancer subtype likely to progress. PLoS One 8, e56761.
26. Toh, B., Wang, X., Keeble, J., Sim, W. J., Khoo, K., Wong, W. C., Kato, M., Prevost-Blondel, A., Thiery, J. P., Abastado, J. P. (2011) Mesenchymal transition and dissemination of cancer cells is driven by myeloid-derived suppressor cells infiltrating the primary tumor. PLoS Biol. 9, e1001162.
27. Melani, C., Sangaletti, S., Barazzetta, F. M., Werb, Z., Colombo, M. P. (2007) Amino-biphosphonate-mediated MMP-9 inhibition breaks the tumor-bone marrow axis responsible for myeloid-derived suppressor cell expansion and macrophage infiltration in tumor stroma. Cancer Res. 67, 11438–11446.
28. Leavenworth, J. W., Verbinnen, B., Wang, Q., Shen, E., Cantor, H. (2015) Intracellular osteopontin regulates homeostasis and function of natural killer cells. Proc. Natl. Acad. Sci. USA 112, 494–499.
29. Leavenworth, J. W., Verbinnen, B., Yin, J., Huang, H., Cantor, H. (2015) A p85α-osteopontin axis couples the receptor ICOS to sustained Bcl-6 expression by follicular helper and regulatory T cells. Nat. Immunol. 16, 96–106.
30. Yan, Q., Weaver, M., Perdue, N., Sage, E. H. (2005) Matricellular protein SPARC is translocated to the nuclei of immortalized murine lens epithelial cells. J. Cell. Physiol. 203, 286–294.
31. Wang, Z., Xiong, S., Mao, Y., Chen, M., Ma, X., Zhou, X., Ma, Z., Liu, F., Huang, Z., Luo, Q., Ouyang, G. (2016) Periostin promotes immunosuppressive premetastatic niche formation to facilitate breast tumour metastasis. J. Pathol. 239, 484–495.
32. Catena, R., Bhattacharya, N., El Rayes, T., Wang, S., Choi, H., Gao, D., Ryu, S., Joshi, N., Bielenberg, D., Lee, S. B., Haukaas, S. A., Gravdal, K., Halvorsen, O. J., Akslen, L. A., Watnick, R. S., Mittal, V. (2013) Bone marrow-derived Gr1+ cells can generate a metastasis-resistant microenvironment via induced secretion of thrombospondin-1. Cancer Discov. 3, 578–589.
33. Wang, S., Blois, A., El Rayes, T., Liu, J. F., Hirsch, M. S., Gravdal, K., Palakurthi, S., Bielenberg, D. R., Akslen, L. A., Drapkin, R., Mittal, V., Watnick, R. S. (2016) Development of a prosaposin-derived therapeutic cyclic peptide that targets ovarian cancer via the tumor microenvironment. Sci. Transl. Med. 8, 329ra34.
34. Chauhan, S., Danielson, S., Clements, V., Edwards, N. J., Ostrand-Rosenberg, S., Fenselau, C. (2017) Surface glycoproteins of exosomes shed by myeloid-derived suppressor cells contribute to function. J. Proteome Res. 16, 238–246.